Palmer, Daniel H <br/><br/>
A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin.  [electronic resource] 

 -  Annals of surgical oncology  Jul 2007 
 - 2088-96 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1068-9265 
<br/><br/><label>Standard No.: </label>10.1245/s10434-007-9384-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Cisplatin--administration & dosage<br/>Deoxycytidine--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Pancreatectomy<br/>Pancreatic Neoplasms--drug therapy<br/>Gemcitabine